TORONTO, ON, August 3, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announced today that Mr. Michael Steele has resigned from the Board of Directors of the Company. “Michael has been a highly valued and [...]
TORONTO, ON, July 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") announces that it has entered into an agreement (the “Credit Agreement”) with the Company’s largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. (the "Lender") to establish a $3.5 million credit facility (the “Facility”) (inclusive of all amounts advanced under [...]
Dear Shareholders, Pathway Health continues to be committed to improving the quality of life for patients suffering from chronic pain and related conditions. At Pathway, we believe medical cannabis will have a role to play in the management of chronic pain, harm reduction for opiate reliance, and will be important to Pathway’s future growth plans. [...]
CALGARY, AB, May 27, 2022 /CNW/ - Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") announces that it has issued a secured promissory grid note (the "Bridge Note") to Avonlea-Drewry Holdings Inc. (the "Lender") for available proceeds to the Corporation of up to Cdn.$1,000,000 (the "Loan"). The Loan has a term of 90 days from the date of [...]
Q1 2022 revenues came in at $2.5 million despite the reintroduction of pandemic restrictions. We will be working with our pharmacy partners to launch the medical cannabis programs in the upcoming quarters. TORONTO, ON, May 20, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), a Canadian [...]
TORONTO, ON, May 10, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), a Canadian leader in chronic pain solutions and management services, announced today that Wayne Cockburn, the Company’s current President, has decided to retire at the end of May following a long career in healthcare, [...]
TORONTO , April 27, 2022 /CNW/ - Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1 ) (formerly Colson Capital Corp.) (" Pathway " or the "Company"), a Canadian leader in chronic pain solutions and management services, is pleased to report its financial results for the three and twelve-month period ended December 31 , 2021. Unless otherwise noted, all amounts are in Canadian dollars and are prepared [...]
TORONTO, ON, April 21, 2021 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, is pleased to announce that it has signed a memorandum of understanding (“MOU”) with Wellbeing Digital [...]
TORONTO, March 4, 2022 /CNW/ - Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly Colson Capital Corp.) ("Pathway" or the "Company"), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces that it has entered into a Letter of Intent (the "LOI") to acquire the operating assets of National Cannabinoid Clinics [...]
Thank you for your continued support of Pathway Health. Although the capital markets have been challenging for our industry and our shareholders alike, 2021 was in fact a transformative year for Pathway Health on a number of fronts. We are pleased to provide a high-level review of the Company’s target markets, achievements during 2021 and our [...]
At Pathway Health, we are committed to delivering personalized care to help improve a patients’ quality of life. We strive to provide patients with timely access to personalized treatment plans using advanced and clinically-proven solutions to achieve the best outcomes.
© Copyright 2023 | Pathway Health
